Conditions guide

Navigating regenerative medicine

Regenerative medicine reaches nearly every part of the body. We focus on the stem-cell-treatable conditions available in the US through our network of doctors and clinics.

Rollout

Where orthopedic procedures are coming online

Statute facts (laws that already took effect) sit next to Forever Labs targets (network and lab readiness). Targets are forecasts — not buy-today claims.

Statute factForever Labs target
  1. Q3 2026

    • Statute · FL

      Florida — available now

      SB 1768 authorizes orthopedic, wound-care, and pain-management stem cell therapy. Forever Labs network physicians practice in Miami and Gulf Breeze.

      Primary source →
    • Statute · TN

      Tennessee HB 2246 in effect

      Orthopedics, wound care, and pain management authorized statewide. Rulemaking still pending; network recruitment in progress.

      Primary source →
    • Statute · WY

      Wyoming Stem Cell Freedom Act in effect

      Autologous MSC pathway with Board of Medicine physician registry. Network recruitment in progress.

      Primary source →
    • Statute · MT

      Montana experimental-treatment rules live

      SB 535 review-board pathway open. Phase 1 safety data required — a different door from Florida-style orthopedic authorization.

  2. Q4 2026

    • Statute · FL

      Florida — available now

      SB 1768 authorizes orthopedic, wound-care, and pain-management stem cell therapy. Forever Labs network physicians practice in Miami and Gulf Breeze.

      Primary source →
    • Target

      Culture expansion & DNA sequencing

      Culture expansion and long-read DNA sequencing planned for Q4 2026 at the Florida cGMP lab. Not a buy-today product on every shelf yet. Banking younger cells now preserves the option.

    • Target · MT

      Montana first treatment centers expected

      Industry reporting points to the first licensed experimental treatment centers around end of 2026. Forever Labs participation is not committed.

    • Target · TN

      Tennessee & Wyoming network build-out

      Laws are live; Forever Labs is recruiting orthopedic network physicians. No committed quarter yet — status flips to available when a provider is published in Payload.

  3. Q1 2027

    • Statute · FL

      Florida — available now

      SB 1768 authorizes orthopedic, wound-care, and pain-management stem cell therapy. Forever Labs network physicians practice in Miami and Gulf Breeze.

      Primary source →
    • Target · AZ

      Arizona SB 1214 outcome window

      Pending bill would expressly cover culture-expanded cells for orthopedics, wound care, and pain management. Outcome depends on the legislature — not a Forever Labs commitment.

      Primary source →
    • Target

      2027 legislative sessions open

      Additional states may introduce Florida-style authorization bills. We track them as statute facts once enacted — never as promises.

  4. Q2 2027

    • Statute · FL

      Florida — available now

      SB 1768 authorizes orthopedic, wound-care, and pain-management stem cell therapy. Forever Labs network physicians practice in Miami and Gulf Breeze.

      Primary source →
    • Target

      Continued network expansion

      Orthopedic coverage beyond Florida depends on provider recruitment in statute-open states. Banking and shipping remain nationwide regardless.

Verified as of July 31, 2026. Therapies described on conditions pages are not FDA-approved. Banking and shipping remain nationwide; the procedure itself must be arranged with your physician.

You are your own best donor

The cells you'd want later are the ones you have today.

Mesenchymal stem cells are the population regenerative medicine studies most, and yours are more numerous and more vigorous now than they will be a decade from now. Banking is how today's cells stay available to your physician later. Why dose and donor age are the variable

  1. Your cells, your biology.

    Autologous means no donor, no waitlist, and no match required. What we store came from you and goes back only at your request.

  2. Younger cells are more vigorous cells.

    MSC counts and proliferative capacity decline with age. Bank at 35 and those cells stay available to the 55-year-old you.

  3. One collection, a larger supply.

    Culture expansion is how a single collection becomes more than a single vial. Dose is the variable separating the same-day trials that landed at parity from the expanded products approved abroad. Rolling out as our Florida cGMP lab comes online.

  4. Ready when you and your physician decide.

    Your cells stay in cryopreservation until you ask for them. What happens next is a conversation with your doctor — Forever Labs stores cells, it does not practice medicine.